6Tsukahara K, Kimura K, Morita S, et al. Impact of concomitantuse of proton-pump inhibitors and thienopyridine derivatives onthe antipiatelet effects[J], J Cardiol,2011,57(3) :275~282.
7Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with orwithout omeprazole in coronary artery disease [J]. N Engl JMed, 2010,363 (20): 1909-1917.
8Simon T, Steg PG, Gilard M, et al. Danchin N, Clinical e-vents as a function of proton pump inhibitor use, clopidogrel use,and cytochrome P450 2C19 genotype in a large nationwide cohortof acute myocardial infarction : results from the French Registryof Acute ST-Elevation and Non-ST-Elevation Myocardial Infarc-tion (FAST-MI) registry [J]. Circulation, 2011,123 (5):474 - 482.
9Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use ofproton pump inhibitors and thienopyridines: a focused update ofthe ACCF/ACG/AHA 2008 expert consensus document on re-ducing the gastrointestinal risks of antiplatelet therapy andNSAID use [J]. Am J Gastroenterol,2010,105( 12) :2533一2549.
10Gremmel T, Steiner S,Seidinger D, et al. Comparison ofmethods to evaluate clopidogrel-mediated platelet inhibition afterpercutaneous intervention with stent implantation [J]. ThrombHaemost,2009,101 (2): 333 - 339.
